Genfit - Clinical Trial for those with limited response to URSO
Condividi questa pagina

Latest News

The PBC Foundation is the only UK based organisation that specifically deals with PBC.

Genfit - Clinical Trial for those with limited response to URSO

Genfit - Clinical Trial for those with limited response to URSO

Are you interested in being involved in a clinical trial in Primary Biliary Cholangitis?

 We are holding an investigational study in PBC for patients who have not experienced an adequate response with Ursodeoxycholic Acid (UDCA or Urso).  If you and your clinician agree that you have not responded adequately to Urso, then you may want to consider enrolling for this study of the drug Elafibranor and its effect on PBC whilst taken with Urso.

To qualify for this study, you must:
•        Be 18 to 75 years of age
•        Have been diagnosed with PBC
•        Have been taking UDCA for at least 12 months and on a stable dose for 6 months or more


If you qualify:
•        All study-related visits, tests, and drugs will be provided at no cost.
•        In addition, reimbursement for study-related travel may be provided
       
More information can be found on the website below:

https://clinicaltrials.gov/ct2/show/study/NCT03124108

Here is a table of participating centres, should you wish to be involved